L. Arlene Nazario, M.D.

Peer-Reviewed Articles

1. Jones D, Cohen L, Rieber AG, Urbauer D, Fellman B, Fisch MJ, Nazario A. Complementary and Alternative Medicine Use in Minority and Medically Underserved Oncology Patients: Assessment and Implications. Integr Cancer Ther 17(2):1534735417735892, 2018. e-Pub 2017. PMID: 29025275.
2. Anderson KO, Palos GR, Mendoza TR, Cleeland CS, Liao KP, Fisch MJ, Garcia-Gonzalez A, Rieber AG, Nazario LA, Valero V, Hahn KM, Person CL, Payne R. Automated pain intervention for underserved minority women with breast cancer. Cancer 121(11):1882-90, 2015. e-Pub 2015. PMID: 25711974.
3. Cleeland CS, Mendoza TR, Wang XS, Woodruff JF, Palos GR, Richman SP, Nazario A, Lynch GR, Liao KP, Mobley GM, Lu C. Levels of Symptom Burden During Chemotherapy for Advanced Lung Cancer: Differences Between Public Hospitals and a Tertiary Cancer Center. J Clin Oncol 29(21):2859-65, 2011. e-Pub 2011. PMID: 21690477.
4. Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, Martin M, Cotrina J, Gomez H, Hubbard R, Chacón JI, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O'Shaughnessy J, Hortobagyi GN, Symmans WF. A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer. JAMA 305(18):1873-81, 2011. PMID: 21558518.
5. Palos GR, Mendoza TR, Liao KP, Anderson KO, Garcia-Gonzalez A, Hahn K, Nazario A, Ramondetta LM, Valero V, Lynch GR, Jibaja-Weiss ML, Cleeland CS. Caregiver symptom burden: The risk of caring for an underserved patient with advanced cancer. Cancer 117(5):1070-9, 2011. e-Pub 2010. PMID: 20960510.
6. Anderson KO, Mendoza TR, Payne R, Valero V, Palos GR, Nazario A, Richman SP, Hurley J, Gning I, Lynch GR, Kalish D, Cleeland CS. Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol 22(24):4918-25, 2004. PMID: 15611506.
7. Nazario A, Amato RJ, Hutchinson L, Bui C, Ellerhorst J, Logothetis CJ. Paclitaxel in extensively pretreated nonseminomatous germ cell tumors. Urologic Oncology 1(5):184-187, 1995. PMID: 21224115.

Abstracts

1. Jones D, Urbauer D, Rieber A, Fisch M, Lee RT, Cohen L, Nazario A. Knowledge of and Interest in Complementary and Alternative Therapies-Results from an Investigational Survey in Minority and Medically Underserved Patients with Cancer. Society of Integrative Oncology Conference 2014, 2014.
2. Palos GR, Mendoza TR, Liao KP, Anderson KO, Garcia-Gonzalez A, Hahn K, Nazario A, Lynch GR, Jibaja-Weiss, Cleeland CS. Predictors of high symptom severity in caregivers of underserved minority cancer patients. Cancer 2010, 2010.
3. Cleeland CS, Mendoza TR, Paols GR, Lu C, Nazario LA, Lynch GR, Mobley GM, Wang XS. Factors contributing ro high symptom burden during chemotherapy for advanced lung cancer: The risk of being underserved. Cancer 2010, 2010.
4. Anderson KO, Palos GR, Garcia-Gonzalez A, Hahn K, Nazario A, Fisch M, Valero V, Ramsey K, Balderas L, Liao KE. Automated pain intervention for underserved minority women with breast cancer. American Cancer Society Disparities Conference, Las Vegas, 2009.
5. Palos GR, Garcia-Gonzalez A, Ramsey K, Liao KP, Balderas L, Anderson KO, Cleeland CS, Hahn K, Nazario A, Jibaja-Weiss ML, Mendoza TR. Cancer symptom burden in underserved minority caregivers. American Cancer Society Disparities Conference, Las Vegas, 2009.
6. Palos GR, Wang XS, Garcia-Gonzalez A, Liao EKP, Ramsey KM, Mobley G, Balderas L, Nazario A, Hahn K, Lynch G, Hurley J, Cleeland CS. Underserved and Undertreated: The Symptom Experience of Advanced Lung Cancer Patients Treated at Public Hospitals. Division of Internal Medicine 2009 Research Retreat, Houston, 2009.
7. Palos GR, Wang XS, Garcia-Gonzalez A, Liao EKP, Ramsey KM, Mobley G, Balderas L, Nazario A, Hahn K, Lynch G, Hurley J, Cleeland CS. Underserved and undertreated: Tracking advanced lung cancer symptoms in patients treated at inner city public hospitals. 10th National Conference on Cancer Nursing Research, Orlando, Fl, 2009.
8. Anderson KO, Mendoza T, Gning I, Palos G, Valero V, Nazario A, Sanchez M, Cleeland CS. Risk Factors for Inadequate Treatment of Cancer-Related Pain Among African American and Latino Cancer Patients. J Clin Oncol 22(24):4918-25, 2004.
9. Anderson KO, Palos G, Gning I, Mendoza TR, Sanchez M, Valero V, Richman SP, Nazario A, Hurley J, Payne R, Cleeland CS. Multi-site randomized trial of pain management education for minority outpatients with cancer pain. Journal of Pain 4:95, 2003.
10. Shinn E, Basen-Engquist K, Carmack Taylor C, Boling W, Rodriguez A, McKirahan N, Rosenblum C, Olvera N, Valero V, Nazario A, Rivera E. Depression and health behaviors in breast cancer survivors. . Annals of Behavioral Medicine 24:S061, 2003.
11. Tsao AS, Kim ES, Nazario A, Fossella FV, Glisson BS, Zinner R, Henderson T, Liu D, Papadimitrakopoulou V, Khuri FR. Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancer as frontline and second-line therapy. Proceedings of American Society of Clinical Oncology 22:691, 2003.
12. Cortes J, Amato R, Nazario A , Zukiwski A , Sella A , Ellerhorst J , Logothetis C. Familial association of germ cell tumors in adults. An update with 15 cases. Proceedings of American Society of Clinical Oncology 13:253, 1994.
13. Nazario A, Amato R, Hutchinson L, Bui C, Sella A, Zukiwski A, Ellerhorst J, Logothetis C. Preliminary results of taxol in patients with refractory or second relapse non-seminomatous germ cell tumors of the testis. Proceedings of the American Association for Cancer Research 35:232, 1994.

Book Chapters

1. Nazario LA, Macheledt JE, Vogel VG. Epidemiology of Cancer and Prevention Strategies. In: Pazdur R, ed., Medical Oncology: A Comprehensive Review 2nd Ed, 661-671, 1995.
2. Nazario LA, Theriault R. Management of Hypercalcemia. In: Pazdur R, ed., Medical Oncology: A Comprehensive Review, 485-490, 1993.